Lenvatinib for the treatment of radio-iodine refractory thyroid cancer in real-life practice |
journalArticle |
2017 |
Berdelou, A.; Borget, I.; Godbert, Y.; Nguyen, T.; Garcia, M. E.; Chougnet, C. N.; Ferru, A.; Buffet, C.; Chabre, O.; Huillard, O.; Leboulleux, S.; Schlumberger, M. |
Reply to the letter to the editor 'Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy' by Siva et al |
journalArticle |
2015 |
de Baère, T.; Aupérin, A.; Deschamps, F.; Chevallier, P.; Gaubert, Y.; Boige, V.; Fonck, M.; Escudier, B.; Palussiére, J. |
A benchmark study of scoring methods for non-coding mutations |
journalArticle |
2018 |
Drubay, D.; Gautheret, D.; Michiels, S. |
Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial |
journalArticle |
2015 |
Borget, I.; Bonastre, J.; Catargi, B.; Déandréis, D.; Zerdoud, S.; Rusu, D.; Bardet, S.; Leenhardt, L.; Bastie, D.; Schvartz, C.; Vera, P.; Morel, O.; Benisvy, D.; Bournaud, C.; Bonichon, F.; Kelly, A.; Toubert, M. E.; Leboulleux, S.; Journeau, F.; Benhamou, E.; Schlumberger, M. |
Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group |
journalArticle |
2016 |
Foulon, S.; Brennan, B.; Gaspar, N.; Dirksen, U.; Jeys, L.; Cassoni, A.; Claude, L.; Seddon, B.; Marec-Berard, P.; Whelan, J.; Paulussen, M.; Streitbuerger, A.; Oberlin, O.; Juergens, H.; Grimer, R.; Le Deley, M. C. |
Sinonasal squamous cell carcinoma without clinical lymph node involvement : Which neck management is best? |
journalArticle |
2016 |
Castelnau-Marchand, P.; Levy, A.; Moya-Plana, A.; Mirghani, H.; Nguyen, F.; Del Campo, E. R.; Janot, F.; Kolb, F.; Ferrand, F. R.; Temam, S.; Blanchard, P.; Tao, Y. |
Bayesian survival analysis in clinical trials: What methods are used in practice? |
journalArticle |
2017 |
Brard, C.; Le Teuff, G.; Le Deley, M. C.; Hampson, L. V. |
A Pharmacokinetic and Pharmacogenetic Analysis of Osteosarcoma Patients Treated With High-Dose Methotrexate: Data From the OS2006/Sarcoma-09 Trial |
journalArticle |
2018 |
Lui, Gabrielle; Treluyer, Jean-Marc; Fresneau, Brice; Piperno-Neumann, Sophie; Gaspar, Nathalie; Corradini, Nadège; Gentet, Jean-Claude; Marec Berard, Perrine; Laurence, Valérie; Schneider, Pascale; Entz-Werle, Natacha; Pacquement, Hélène; Millot, Frédéric; Taque, Sophie; Freycon, Claire; Lervat, Cyril; Le Deley, Marie Cécile; Mahier Ait Oukhatar, Céline; Brugieres, Laurence; Le Teuff, Gwénaël; Bouazza, Naïm; Sarcoma Group of UNICANCER |
Management of locoregional recurrence after radical resection of a primary nonmetastatic retroperitoneal soft tissue sarcoma: The Gustave Roussy experience |
journalArticle |
2018 |
Honore, C.; Faron, M.; Mir, O.; Haddag-Miliani, L.; Dumont, S.; Terrier, P.; LePechoux, C.; Botticella, A.; Adam, J.; Le Cesne, A. |
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma |
journalArticle |
2015 |
Hadoux, J.; Malka, D.; Planchard, D.; Scoazec, J. Y.; Caramella, C.; Guigay, J.; Boige, V.; Leboulleux, S.; Burtin, P.; Berdelou, A.; Loriot, Y.; Duvillard, P.; Chougnet, C. N.; Déandréis, D.; Schlumberger, M.; Borget, I.; Ducreux, M.; Baudin, E. |
Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer |
journalArticle |
2016 |
Lamartina, L.; Ippolito, S.; Danis, M.; Bidault, F.; Borget, I.; Berdelou, A.; Al Ghuzlan, A.; Hartl, D.; Blanchard, P.; Terroir, M.; Deandreis, D.; Schlumberger, M.; Baudin, E.; Leboulleux, S. |
Preface |
journalArticle |
2016 |
Heinze, G.; Michiels, S.; Posch, M. |
Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors |
journalArticle |
2018 |
Bahleda, R.; Le Deley, M. C.; Bernard, A.; Chaturvedi, S.; Hanley, M.; Poterie, A.; Gazzah, A.; Varga, A.; Touat, M.; Deutsch, E.; Massard, C.; Van De Velde, H.; Hollebecque, A.; Sallansonnet-Froment, M.; Ricard, D.; Taillia, H.; Angevin, E.; Ribrag, V.; Soria, J. C. |
The postoperative occurrence or worsening of diabetes mellitus may increase the risk of recurrence in resected pancreatic neuroendocrine tumors |
journalArticle |
2019 |
de Mestier, L.; Vedie, A. L.; Faron, M.; Cros, J.; Rebours, V.; Hentic, O.; Do Cao, C.; Bardet, P.; Levy, P.; Sauvanet, A.; Ruszniewski, P.; Hammel, P. |
Does smoking alter the mutation profile of human papillomavirus-driven head and neck cancers? |
journalArticle |
2018 |
Mirghani, H.; Lacroix, L.; Rossoni, C.; Sun, R.; Aupérin, A.; Casiraghi, O.; Villepelet, A.; Lacave, R.; Faucher, G.; Marty, V.; Ferté, C.; Soria, J. C.; Even, C. |
Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates |
journalArticle |
2018 |
Espin, J.; Schlander, M.; Godman, B.; Anderson, P.; Mestre-Ferrandiz, J.; Borget, I.; Hutchings, A.; Flostrand, S.; Parnaby, A.; Jommi, C. |
INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVES |
journalArticle |
2015 |
Martelli, N.; Billaux, M.; Borget, I.; Pineau, J.; Prognon, P.; van den Brink, H. |
MRI-guided brachytherapy in locally advanced cervical cancer: Small bowel [Formula: see text] and [Formula: see text] are not predictive of late morbidity |
journalArticle |
2016 |
Petit, C.; Dumas, I.; Chargari, C.; Martinetti, F.; Maroun, P.; Doyeux, K.; Tailleur, A.; Haie-Meder, C.; Mazeron, R. |
Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: A report from the PETRUS prospective study |
journalArticle |
2016 |
Massard, C.; Oulhen, M.; Le Moulec, S.; Auger, N.; Foulon, S.; Abou-Lovergne, A.; Billiot, F.; Valent, A.; Marty, V.; Loriot, Y.; Fizazi, K.; Vielh, P.; Farace, F. |
Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease |
journalArticle |
2018 |
Danlos, F. X.; Voisin, A. L.; Dyevre, V.; Michot, J. M.; Routier, E.; Taillade, L.; Champiat, S.; Aspeslagh, S.; Haroche, J.; Albiges, L.; Massard, C.; Girard, N.; Dalle, S.; Besse, B.; Laghouati, S.; Soria, J. C.; Mateus, C.; Robert, C.; Lanoy, E.; Marabelle, A.; Lambotte, O. |
Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experience |
journalArticle |
2016 |
Bluthgen, M. V.; Boutros, C.; Fayard, F.; Remon, J.; Planchard, D.; Besse, B. |
Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC |
journalArticle |
2015 |
Strullu, M.; Thomas, C.; Le Deley, M. C.; Chevance, A.; Kanold, J.; Bertrand, Y.; Jubert, C.; Dalle, J. H.; Paillard, C.; Baruchel, A.; Lamant, L.; Michel, G.; Brugieres, L. |
Telomere shortening: a new prognostic factor for cardiovascular disease post-radiation exposure |
journalArticle |
2015 |
M'Kacher, R.; Girinsky, T.; Colicchio, B.; Ricoul, M.; Dieterlen, A.; Jeandidier, E.; Heidingsfelder, L.; Cuceu, C.; Shim, G.; Frenzel, M.; Lenain, A.; Morat, L.; Bourhis, J.; Hempel, W. M.; Koscielny, S.; Paul, J. F.; Carde, P.; Sabatier, L. |
Emerging Role of Multikinase Inhibitors in Desmoid Tumor Management |
journalArticle |
2019 |
Penel, N.; Ryckewaert, T.; Le Deley, M. C. |
The decision-making capacity of elderly hospitalized patients: validation of a test on their choice of return home |
journalArticle |
2018 |
Romdhani, M.; Abbas, R.; Peyneau, C.; Koskas, P.; Houenou Quenum, N.; Galleron, S.; Drunat, O. |
In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies? |
journalArticle |
2017 |
Aspeslagh, S.; Matias, M.; Palomar, V.; Dercle, L.; Lanoy, E.; Soria, J. C.; Postel-Vinay, S. |
Uncovering Professional Attitudes Toward Treatment of Rare Carcinomas of the Breast: An International Practice e-Survey Involving 32 Countries |
journalArticle |
2016 |
Saghatchian, M.; Fadoukhair, Z.; Hofert, K.; Lanoy, E.; Mathieu, M. C.; Mazouni, C.; Delaloge, S. |
biospear: an R package for biomarker selection in penalized Cox regression |
journalArticle |
2018 |
Ternes, N.; Rotolo, F.; Michiels, S. |
Choline Positron Emission Tomography/Computed Tomography for Selection of Patients for Salvage Strategies After Primary Local Treatment of Prostate Cancer and Rising Prostate-specific Antigen: Ready for Prime Time? |
journalArticle |
2017 |
Bossi, A.; Mottet, N.; Blanchard, P. |
Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis |
journalArticle |
2018 |
Guerrini-Rousseau, L.; Dufour, C.; Varlet, P.; Masliah-Planchon, J.; Bourdeaut, F.; Guillaud-Bataille, M.; Abbas, R.; Bertozzi, A. I.; Fouyssac, F.; Huybrechts, S.; Puget, S.; Bressac-De Paillerets, B.; Caron, O.; Sevenet, N.; Dimaria, M.; Villebasse, S.; Delattre, O.; Valteau-Couanet, D.; Grill, J.; Brugières, L. |
The Use of Indirect Comparisons in Medicines Evaluation for their Access To Reimbursement by the Has |
journalArticle |
2015 |
Guichard, M.; D'Andon, A.; Rumeau Pichon, C.; Borget, I. |
Joint model for left-censored longitudinal data, recurrent events and terminal event: Predictive abilities of tumor burden for cancer evolution with application to the FFCD 2000-05 trial |
journalArticle |
2016 |
Krol, A.; Ferrer, L.; Pignon, J. P.; Proust-Lima, C.; Ducreux, M.; Bouche, O.; Michiels, S.; Rondeau, V. |
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer |
journalArticle |
2016 |
Gouy, S.; Ferron, G.; Glehen, O.; Bayar, A.; Marchal, F.; Pomel, C.; Quenet, F.; Bereder, J. M.; Le Deley, M. C.; Morice, P. |
Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial |
journalArticle |
2018 |
Bahig, H.; Yuan, Y.; Mohamed, A. S. R.; Brock, K. K.; Ng, S. P.; Wang, J.; Ding, Y.; Hutcheson, K.; McCulloch, M.; Balter, P. A.; Lai, S. Y.; Al-Mamgani, A.; Sonke, J. J.; van der Heide, U. A.; Nutting, C.; Li, X. A.; Robbins, J.; Awan, M.; Karam, I.; Newbold, K.; Harrington, K.; Oelfke, U.; Bhide, S.; Philippens, M. E. P.; Terhaard, C. H. J.; McPartlin, A. J.; Blanchard, P.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Phan, J.; Cazoulat, G.; Aristophanous, M.; McSpadden, K. K.; Garcia, J. A.; van den Berg, C. A. T.; Raaijmakers, C. P. J.; Kerkmeijer, L.; Doornaert, P.; Blinde, S.; Frank, S. J.; Fuller, C. D. |
Nasopharyngeal carcinoma |
journalArticle |
2019 |
Chen, Y. P.; Chan, A. T. C.; Le, Q. T.; Blanchard, P.; Sun, Y.; Ma, J. |
All simulation models of breast cancer are wrong but some are useful |
journalArticle |
2018 |
Michiels, S.; Delaloge, S. |
Designs of preoperative biomarkers trials in oncology: a systematic review of the literature |
journalArticle |
2015 |
Marous, M.; Bieche, I.; Paoletti, X.; Alt, M.; Razak, A. R.; Stathis, A.; Kamal, M.; Le Tourneau, C. |
Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma |
journalArticle |
2016 |
Peeler, C. R.; Mirkovic, D.; Titt, U.; Blanchard, P.; Gunther, J. R.; Mahajan, A.; Mohan, R.; Grosshans, D. R. |
New French Coverage with Evidence Development for Innovative Medical Devices: Improvements and Unresolved Issues |
journalArticle |
2016 |
Martelli, N.; van den Brink, H.; Borget, I. |
A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer |
journalArticle |
2018 |
Criscitiello, C.; Bayar, M. A.; Curigliano, G.; Symmans, F. W.; Desmedt, C.; Bonnefoi, H.; Sinn, B.; Pruneri, G.; Vicier, C.; Pierga, J. Y.; Denkert, C.; Loibl, S.; Sotiriou, C.; Michiels, S.; André, F. |